13FPulse
GH

GH GUARDANT HEALTH INC

2026Q2 · CUSIP 40131M109 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
584
Institutions that reported holding it to the SEC
Net increase in holders
+100
Last quarter 484 → now 584
How unusual is that
Top 5%
Stronger buying than 98% of US stocks
What the filings say, in one paragraph

584 funds held GH at the end of 2026Q2, up 100 from the quarter before. That is stronger buying than 98.2% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $1.2B(YoY +42.7%). GH has had 16 buying rushes in its history, and the price moved +28.3% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q1: holders=149 2019Q2: holders=217 2019Q3: holders=239 2019Q4: holders=264 2020Q1: holders=286 2020Q2: holders=322 2020Q3: holders=344 2020Q4: holders=414 2021Q1: holders=413 2021Q2: holders=411 2021Q3: holders=371 2021Q4: holders=393 2022Q1: holders=354 2022Q2: holders=327 2022Q3: holders=327 2022Q4: holders=293 2023Q1: holders=277 2023Q2: holders=297 2023Q3: holders=294 2023Q4: holders=295 2024Q1: holders=255 2024Q2: holders=282 2024Q3: holders=270 2024Q4: holders=298 2025Q1: holders=339 2025Q2: holders=364 2025Q3: holders=395 2025Q4: holders=497 2026Q1: holders=484 2026Q2: holders=584 -102 -51 +0 +51 +102 134374614 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 16 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 5%
2025Q4 Top 5% +8.1%
2025Q3 Top 10% +10.3% +19.2%
2025Q2 Top 20% +58.7% +80.6%
2025Q1 Top 5% +45.6% +139.8%
2024Q4 Top 20% -15.5% +23.6%
2024Q2 Top 10% +8.1% +75.3%
2023Q2 Top 20% -30.3% -37.1%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
244
Change in large funds
+38
Total value they hold
$20.0B
Funds buying for the first time
152
Funds that sold out entirely
52
Price change that quarter
+68.8%
Funds holding puts (bearish)
13
Funds holding calls (bullish)
11

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-3.50
EPS YoY
Revenue (TTM)
$1.2B
Revenue YoY
+42.7%
Net margin
-38.3%
ROE
Debt ratio
111.7%
FCF (TTM)
-$241M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2022-09-30: EPS -1.58 2022-12-31: EPS -1.37 2023-03-31: EPS -1.30 2023-06-30: EPS -0.67 2023-09-30: EPS -0.73 2023-12-31: EPS -1.58 2024-03-31: EPS -0.94 2024-06-30: EPS -0.84 2024-09-30: EPS -0.88 2024-12-31: EPS -0.90 2025-03-31: EPS -0.77 2025-06-30: EPS -0.80 2025-09-30: EPS -0.74 2025-12-31: EPS -1.01 2026-03-31: EPS -0.85 2026-06-30: EPS -0.90 0M 167M 335M $M -1.74 -0.87 0.00 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-135M-67M0K 2017201820192020202120222023202420252026
Latest quarter $-71M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.